Money Never Sleeps Radio with Louis Velazquez

Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance

Early signs from the launch of Novo Nordisk’s Wegovy pill and Eli Lilly & Co.’s Foundayo are making investors rethink the opportunity for GLP-1 pills.

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright, All Rights Reserved © UCWE Media